ABBV
Price:
$193.4
Market Cap:
$341.61B
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pan...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-01-02
Stock Exchange
NYSE
Ticker
ABBV
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.81. This represents a change of -9.62% compared to the average of 0.89 of the last 4 quarters.
The mean historical Current Ratio of AbbVie Inc. over the last ten years is 1.35. The current 0.81 Current Ratio has changed 5.89% with respect to the historical average. Over the past ten years (40 quarters), ABBV's Current Ratio was at its highest in in the December 2019 quarter at 3.18. The Current Ratio was at its lowest in in the December 2021 quarter at 0.79.
Average
1.35
Median
1.13
Minimum
0.79
Maximum
3.18
Discovering the peaks and valleys of AbbVie Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 223.25%
Maximum Annual Current Ratio = 3.18
Minimum Annual Increase = -73.46%
Minimum Annual Current Ratio = 0.79
Year | Current Ratio | Change |
---|---|---|
2023 | 0.87 | -9.49% |
2022 | 0.96 | 21.43% |
2021 | 0.79 | -5.91% |
2020 | 0.84 | -73.46% |
2019 | 3.18 | 223.25% |
2018 | 0.98 | -22.93% |
2017 | 1.28 | -22.94% |
2016 | 1.65 | 10.51% |
2015 | 1.50 | 6.11% |
2014 | 1.41 | -45.61% |
The current Current Ratio of AbbVie Inc. (ABBV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.88
5-year avg
1.33
10-year avg
1.35
AbbVie Inc.’s Current Ratio is less than Merck & Co., Inc. (1.47), less than Pfizer Inc. (0.86), less than Eli Lilly and Company (1.11), less than Bristol-Myers Squibb Company (1.16), less than Johnson & Johnson (1.07), less than Amgen Inc. (1.26), less than Gilead Sciences, Inc. (1.14),
Company | Current Ratio | Market cap |
---|---|---|
1.47 | $298.70B | |
0.86 | $161.84B | |
1.11 | $857.96B | |
1.16 | $98.73B | |
1.07 | $395.70B | |
1.26 | $172.25B | |
1.14 | $98.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is AbbVie Inc.'s Current Ratio?
How is the Current Ratio calculated for AbbVie Inc. (ABBV)?
What is the highest Current Ratio for AbbVie Inc. (ABBV)?
What is the 3-year average Current Ratio for AbbVie Inc. (ABBV)?
What is the 5-year average Current Ratio for AbbVie Inc. (ABBV)?
How does the current Current Ratio for AbbVie Inc. (ABBV) compare to its historical average?